Page last updated: 2024-08-25

3-deazaneplanocin and irinotecan

3-deazaneplanocin has been researched along with irinotecan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hosokawa, M; Kono, Y; Ogawara, KI; Tetsumoto, S; Yasui, M	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and irinotecan

Article	Year
3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells. Biochemical and biophysical research communications, 2023, 10-15, Volume: 677 Topics: Animals; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histone Methyltransferases; Histones; Humans; Irinotecan; Melanoma; Mice; RNA, Small Interfering; Tumor Microenvironment	2023

Article

Year

3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells.

Biochemical and biophysical research communications, 2023, 10-15, Volume: 677

Topics: Animals; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histone Methyltransferases; Histones; Humans; Irinotecan; Melanoma; Mice; RNA, Small Interfering; Tumor Microenvironment

2023